Afficher la notice abrégée

dc.contributor.authorCarr, Anitra C.
dc.date.accessioned2025-03-08T02:54:03Z
dc.date.available2025-03-08T02:54:03Z
dc.date.issued2020
dc.date.submitted2020-07-27T09:55:35Z
dc.identifierhttps://library.oapen.org/handle/20.500.12657/40107
dc.identifier.urihttps://doab-dev.siscern.org/handle/20.500.12854/176512
dc.description.abstractIn humans, ascorbic acid is an essential vitamin, anti-oxidant and co-factor of a variety of metal ion-dependent enzymatic reactions. In this review, the transport of L-ascorbic acid is described from food to target cells. Transport of ascorbic acid across the plasma membrane is facilitated by members of the SLC23 family, SLC23A1/SVCT1 and SLC23A2/SVCT2. We present in silico models of these transporters that provide new insights into the structure of the SLC23 family. While SVCT1 is mainly responsible for uptake of ascorbic acid from the intestine into the blood and for reabsorption in the kidney, the more broadly expressed transporter SVCT2 delivers ascorbic acid into tissues that are in high demand of the vitamin. The oxidized form of ascorbic acid, dehydroascorbic acid (DHA), is a substrate of the GLUT transporters belonging to the SLC2 family. They play important roles in ascorbic acid recycling, such as in the brain and in erythrocytes. Ascorbic acid serves as an essential co-factor of metal ion-dependent enzymes, keeping their metal ions in the reduced state. In addition, it serves as an effective antioxidant in cells with high metabolic activity such as neurons. Thus, it is not too surprising that changes in expression and function of the SVCTs have nutritional and pathological consequences such as during ageing, malnutrition and chronic alcohol abuse or in cancer, neurodegenerative diseases and chronic inflammation diseases. In the future, SVCT1 and SVCT2 may furthermore prove useful as drug delivery systems, to enhance transport of novel pharmaceutical agents more efficiently across the intestinal epithelium and the blood-cerebrospinal fluid barrier.
dc.languageEnglish
dc.rightsopen access
dc.subject.otherantioxidants
dc.subject.otherascorbic acid
dc.subject.otherinfectious disease
dc.subject.otherintravenous ascorbate
dc.subject.otherthema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
dc.subject.otherthema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSD Molecular biology
dc.subject.otherthema EDItEUR::P Mathematics and Science::PS Biology, life sciences
dc.titleChapter 7 Vitamin C in Pneumonia and Sepsis
dc.typechapter
oapen.relation.isPublishedByfa69b019-f4ee-4979-8d42-c6b6c476b5f0
oapen.relation.isPartOfBook061da74a-5b40-4982-b1c8-0ff51b5cf551
oapen.relation.isbn9780429442025
oapen.imprintCRC Press
oapen.pages26
dc.anonymitySingle-anonymised
dc.peerreviewidbc80075c-96cc-4740-a9f3-a234bc2598f1
dc.peerreviewtitleProposal review
dc.openreviewNo
dc.responsibilityPublisher
dc.stagePre-publication
dc.reviewtypeProposal
dc.reviewertypeInternal editor
dc.reviewertypeExternal peer reviewer


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée